Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin J Doranz

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Cell Reports|April 8, 2023
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypesElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Ebiomedicine|April 22, 2020
Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infectionAdam T Waickman, Gregory D Gromowski, Wiriya Rutvisuttinunt, et al.
Cell Reports|September 30, 2021
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognitionKevin J Kramer, Nicole V Johnson, Andrea R Shiakolas, et al.
Cell|January 26, 2016
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus InfectionAndrew I Flyak, Xiaoli Shen, Charles D Murin, et al.
Cell|August 20, 2021
Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitopeArthur S Kim, Natasha M Kafai, Emma S Winkler, et al.
Cell|May 20, 2017
Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of VulnerabilityXuelian Zhao, Katie A Howell, Shihua He, et al.
Cell|August 20, 2021
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egressLauren E Williamson, Kristen M Reeder, Kevin Bailey, et al.
Cell Reports|November 15, 2018
In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse ModelAmi Patel, Daniel H Park, Carl W Davis, et al.
Journal of Virology|July 3, 2023
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus ActivityJaime L Jensen, Rajeshwer S Sankhala, Vincent Dussupt, et al.
Cell Reports|May 11, 2016
Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding SiteKatie A Howell, Xiangguo Qiu, Jennifer M Brannan, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Cell Reports|April 8, 2023
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypesElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Ebiomedicine|April 22, 2020
Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infectionAdam T Waickman, Gregory D Gromowski, Wiriya Rutvisuttinunt, et al.
Cell Reports|September 30, 2021
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognitionKevin J Kramer, Nicole V Johnson, Andrea R Shiakolas, et al.
Cell|January 26, 2016
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus InfectionAndrew I Flyak, Xiaoli Shen, Charles D Murin, et al.
Cell|August 20, 2021
Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitopeArthur S Kim, Natasha M Kafai, Emma S Winkler, et al.
Cell|May 20, 2017
Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of VulnerabilityXuelian Zhao, Katie A Howell, Shihua He, et al.
Cell|August 20, 2021
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egressLauren E Williamson, Kristen M Reeder, Kevin Bailey, et al.
Cell Reports|November 15, 2018
In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse ModelAmi Patel, Daniel H Park, Carl W Davis, et al.
Journal of Virology|July 3, 2023
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus ActivityJaime L Jensen, Rajeshwer S Sankhala, Vincent Dussupt, et al.
Cell Reports|May 11, 2016
Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding SiteKatie A Howell, Xiangguo Qiu, Jennifer M Brannan, et al.
Pageof 10